RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 128 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 500 | -89.6% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 4,800 | +2300.0% | 0.00% | – |
| Q1 2023 | $1 | -92.3% | 200 | -98.0% | 0.00% | -100.0% |
| Q4 2022 | $13 | -100.0% | 9,900 | -54.2% | 0.00% | -83.3% |
| Q3 2022 | $90,000 | +1700.0% | 21,600 | +1076.5% | 0.01% | – |
| Q2 2022 | $5,000 | -76.2% | 1,836 | -21.4% | 0.00% | -100.0% |
| Q1 2022 | $21,000 | -90.6% | 2,336 | -85.2% | 0.00% | -90.9% |
| Q2 2021 | $224,000 | -12.5% | 15,818 | -8.0% | 0.01% | -15.4% |
| Q1 2021 | $256,000 | +71.8% | 17,202 | +81.1% | 0.01% | +85.7% |
| Q4 2020 | $149,000 | +10.4% | 9,500 | -18.1% | 0.01% | -22.2% |
| Q3 2020 | $135,000 | +575.0% | 11,600 | +1060.0% | 0.01% | +800.0% |
| Q2 2020 | $20,000 | – | 1,000 | +150.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 400 | +100.0% | 0.00% | – |
| Q4 2019 | $2,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |